Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-02-14

Clinical Trial Update: Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 trial comparing Busulfan plus Cyclophosphamide versus Fludarabine as conditioning regimens for patients with leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Fludarabine (Fludarabine)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Leukemia, Myelodysplastic Syndrome | Phase 3 | Status: COMPLETED